Students and faculty members in U of A's Department of Agricultural Education, Communications and Technology presented research at the annual American Association for Agricultural Education conference ...

Presentation Details: Title: Phase 1 clinical trial of autologous T-cells genetically engineered with a chimeric receptor to target the follicle stimulating hormone receptor (FSHR) in recurrent ...

Details of the Poster Presentations. Poster Number: 750-P. Abstract Title: ASC30, an Oral GLP-1R Biased Small Molecule Agonist in Participants with Obesity—A First-in-Human Single Ascending Dose ...

Details on the presentation can be found below. A copy of the Company's poster presentation will be available under the Scientific Presentations tab of the Tonix website at following the conference.

REHOVOT, Israel, June 04, 2025 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. ("Purple Biotech" or "the Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class therapies that seek ...

Projects or research described in the speed presentation/poster should, directly or indirectly, deal with Invasive Alien Predators. Abstracts are obligatory and posters to accompany the talks in the ...

DA-1241 is a novel G-Protein-Coupled Receptor 119 (GPR119) agonist with development optionality as a standalone and/or combination therapy for both MASH and type 2 diabetes (T2D). Agonism of ...

Purple Biotech Announces Poster Presentation at EACR 2025 on its Novel CAPTN-3 Tri-Specific Antibody Platform Provided by GlobeNewswire Jun 4, 2025, 11:00:00 AM ...

Download this Modern Geometric Abstract Presentation Posters vector illustration now. And search more of iStock's library of royalty-free vector art that features Abstract graphics available for quick ...

Environmental Studies Thesis Poster Presentation. All Environmental Studies majors participate in public poster presentations as part of the thesis process. A poster session is organized for Wednesday ...

Poster Session. Abstract: TPS8666. Poster Bd #136b. 1.30pm. A phase 2 safety and efficacy study of PRT3789 in combination with pembrolizumab in patients with advanced or metastatic solid tumors and a ...

--BeyondSpring Inc., a clinical-stage global biopharmaceutical company focused on developing cancer therapies, today announces that it will have a poster presentation on 303 Study, the ...